Shanghai Kai Kai Industry Co Ltd
SSE:600272
Shanghai Kai Kai Industry Co Ltd
Income from Continuing Operations
Shanghai Kai Kai Industry Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Kai Kai Industry Co Ltd
SSE:600272
|
Income from Continuing Operations
¥55.1m
|
CAGR 3-Years
74%
|
CAGR 5-Years
10%
|
CAGR 10-Years
0%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Income from Continuing Operations
¥6.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income from Continuing Operations
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income from Continuing Operations
¥3.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income from Continuing Operations
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income from Continuing Operations
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Shanghai Kai Kai Industry Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
55.1m
CNY
Based on the financial report for Mar 31, 2024, Shanghai Kai Kai Industry Co Ltd's Income from Continuing Operations amounts to 55.1m CNY.
What is Shanghai Kai Kai Industry Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%
Over the last year, the Income from Continuing Operations growth was 32%. The average annual Income from Continuing Operations growth rates for Shanghai Kai Kai Industry Co Ltd have been 74% over the past three years , 10% over the past five years .